Last update 08 May 2025

HRF-10071

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action
inhibitors
Mechanism
HIV replication inhibitors
Therapeutic Areas
Immune System DiseasesInfectious DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
HIV Infections
Originator Organization
Hetero Drugs Ltd.Hetero Drugs Ltd.
Active Organization-
Inactive Organization
Hetero Drugs Ltd.Hetero Drugs Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

8
Clinical Trials associated with HRF-10071
CTRI/2024/07/070445
/ Not yet recruitingNot Applicable
A PHASE - 1, OPEN-LABEL, NON-RANDOMIZED, MULTIPLE-DOSE, TWO-TREATMENT, SINGLE SEQUENCE, DRUG-DRUG INTERACTION STUDY TO ASSESS PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD), SAFETY, AND TOLERABILITY OF AN ORAL CONTRACEPTIVE CONTAINING ETHINYL ESTRADIOL (EE) 0.03 MG AND LEVONORGESTREL (LNG) 0.15 MG TABLET WHEN ADMINISTERED ALONE AND IN COMBINATION WITH HRF-10071 TABLET 120 MG IN HEALTHY, ADULT, HUMAN FEMALE SUBJECTS UNDER FASTING CONDITION. - NIL
CTRI/2022/12/048577
/ Active, not recruitingPhase 2
A Phase IIa, Multicenter, Randomized, Double Blind, Parallel, Placebo Controlled, Proof of Concept Study to Assess the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of HRF-10071(Test Product, Manufactured by Hetero Labs Limited, India) 80mg & 120mg Tablets Once Daily Orally in Antiretroviral Treatment-naïve HIV Infected Patients.
CTRI/2022/10/046158
/ Not yet recruitingPhase 1
A Phase 1, Multiple-dose, Two-treatment, Three-period, Nonrandomized Fixed Sequence, Steady State, Two-way Interaction Study Under Fasting Conditions to Evaluate the Pharmacokinetic Interactions Between HRF-10071, Darunavir and Ritonavir.
100 Clinical Results associated with HRF-10071
Login to view more data
100 Translational Medicine associated with HRF-10071
Login to view more data
100 Patents (Medical) associated with HRF-10071
Login to view more data
100 Deals associated with HRF-10071
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 1
India
Hetero Drugs Ltd.Hetero Drugs Ltd.
30 Aug 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free